The Impact of Streptozotocin‐Induced Diabetes on the Minimum Alveolar Anesthetic Concentration (MAC) of Inhaled Anesthetics in the Rat
The Impact of Streptozotocin‐Induced Diabetes on the Minimum Alveolar Anesthetic Concentration (MAC) of Inhaled Anesthetics in the Rat
复制标题
DOI:
10.1213/00000539-199308000-00022
复制
发表时间:
1993-08
影响因子:
5.7
通讯作者:
J. E. Brian;Laura Bogan;R. Kennedy;Ernst Seifen
中科院分区:
文献类型:
--
作者:
J. E. Brian;Laura Bogan;R. Kennedy;Ernst Seifen
&NA; We designed experiments to examine the effects of insulin‐dependent diabetes mellitus on the anesthetic requirements for volatile anesthetics. A standard tailclamp technique was used to determine minimum alveolar anesthetic concentrations for halothane, enflurane, and isoflurane in spontaneously breathing rats. Three groups of animals were used: 1) diabetic rats (12 wk after induction of diabetes with streptozotocin, 50 mg/kg, single dose, intravenously), 2) insulintreated (7 U extended insulin zinc suspension per day, subcutaneously, beginning 5 wk after streptozotocin treatment) diabetic rats, and 3) control rats. The minimum alveolar anesthetic concentration values of the control animals were 1.16 ± 0.02 vol% for halothane, 2.25 ± 0.05 vol% for enflurane, and 1.42 ± 0.04 vol% for isoflurane. Minimum alveolar anesthetic concentration was reduced by 23% for halothane (0.90 ± 0.06 vol%), by 18% for enflurane (1.85 ± 0.07 vol%), and by 17% for isoflurane (1.18 ± 0.04 vol%) in diabetic rats. Insulin treatment restored the anesthetic requirement to control levels for all three anesthetics. These data from the rat model indicate that uncontrolled diabetes lowers anesthetic requirements significantly. (Anesth Analg 1993;77:342‐5)